CAN FITE BIO

About CAN FITE BIO

Can-Fite BioPharma (Nasdaq: CANF) is a developer of proprietary small-molecule drugs. In early 2026, the company is hitting critical milestones, including an expected interim analysis for its Phase 3 liver cancer trial and efficacy data for its Phase 2a pancreatic cancer program.